(Q83782025)
Statements
Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients (English)
Kenneth E Truitt
James B Moberly
Daniel M Ford
Hamim Zahir
Shuquan Chen
Takashi Mochizuki
Timothy L Vollmer